Use of biosimilar therapies in adult patients diagnosed with juvenile idiopathic arthritis: results from the Spanish registry of adverse events with biologic therapies (BIOBADASER)
14/08/2023
J. J. Bethencourt Baute1, L. Otero-Varela2, F. J. Manero Ruiz3, E. Perez-Pampín4, C. Rodríguez-Lozano5, S. Manrique Arija6, S. Bustabad7, C. Fernández-López8, D. Ruiz Montesinos9, L. Mateo10, R. Martín-Domenech11, M. Moreno12, F. Sánchez-Alonso2, I. Catrejón13
EULAR 2023
DOI: 10.1136/annrheumdis-2023-eular.4406
http://scientific.sparx-ip.net/archiveeular/?c=a&view=1&searchfor=biobadaser&item=2023AB1423